Rho-kinase is involved in mouse blastocyst cavity formation

Biochem Biophys Res Commun. 2004 Jun 25;319(2):643-8. doi: 10.1016/j.bbrc.2004.05.040.

Abstract

During mammalian embryonic development, the formation and subsequent expansion of a fluid-filled cavity, the blastocoel, is crucial for successful implantation. Our present experiments were aimed at exploring the contribution of Rho-kinase, a downstream effector of the small GTP-binding protein RhoA, to mouse blastocoel formation. RT-PCR analysis showed that Rho-kinase mRNA is present throughout mouse preimplantation development. When 2-cell embryos were cultured in the presence of a specific inhibitor of Rho-kinase, Y-27632, they developed to the morula stage but failed to develop to the blastocyst stage. Y-27632 inhibited the formation of the blastocoel cavity from the morula stage, and this inhibitory effect was reversible when embryos were returned to medium without Y-27632. Moreover, Y-27632 reduced the rate of re-expansion of blastocysts collapsed by cytochalasin D upon transfer to the control medium. These results suggest that Rho-kinase is likely involved in blastocyst formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Animals
  • Blastocyst / cytology*
  • Blastocyst / enzymology
  • Embryonic and Fetal Development
  • Enzyme Inhibitors / pharmacology
  • Intracellular Signaling Peptides and Proteins
  • Mice
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • rho-Associated Kinases

Substances

  • Amides
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Pyridines
  • RNA, Messenger
  • Y 27632
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases